Patient Square Capital
Investor profile
Venture capital
Patient Square Capital has backed 2 European tech companies across 2 funding rounds between 2022 and 2024, joining rounds totalling €141M. Most active in Healthtech. Data as of 4 Nov 2026.
Deals
2
distinct rounds
Companies
2
backed
Active span
2022–2024
3 yrs
Total round €
€141M
sum of rounds joined
Deals by year
distinct rounds / yearPatient Square Capital — deals by year — interactive chart.
Data table
| Patient Square Capital — deals by year | |
|---|---|
| 2022 | 1 |
| 2024 | 1 |
Top sectors
by dealsPatient Square Capital — top sectors — interactive chart.
Data table
| Patient Square Capital — top sectors | |
|---|---|
| Healthtech | 2 |
Stages
by dealsPatient Square Capital — stages — interactive chart.
Data table
| Patient Square Capital — stages | |
|---|---|
| Series A | 1 |
| Series B | 1 |
Countries
by dealsPatient Square Capital — countries — interactive chart.
Data table
| Patient Square Capital — countries | |
|---|---|
| Germany | 1 |
| UK | 1 |
Co-investment network
shared roundsCo-investment network — interactive chart.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
Frequent co-investors
shared roundsPortfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Resolve Biosciences | Germany | 1 | €72M |
| Nuclera | UK | 1 | €69M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Resolve Biosciences | Series B | €72M | 2022-10 |
| Nuclera | Series A | €69M | 2024-10 |